Site Search
Search Results
Increasing Access to Biomarker Testing - SB496 (Limón)
Summary: SB 496 (Limón) will increase access to biomarker testing, ensuring patients receive the right treatment at the right time. Need for bill: Precision medicine is dramatically improving cancer outcomes by using information about a person’s own genes or proteins (biomarkers) to prevent, diagnose, or treat disease. Advances in biomarker testing and cancer treatments now allow for targeted cancer therapies that can improve patient survival and quality of life. Testing ...
Legislation Introduced to Increase Californians’ Access to Biomarker Testing, the Key to Precision Medicine
Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced legislation to ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 496 aims to enable more Californians to benefit from biomarker testing, a critical step for accessing precision medicine, including targeted therapies, that can lead to improved survivorship and ...
Governor Newsom’s Veto of Legislation to Expand Access to Biomarker Testing Fails Cancer Patients
Sacramento , Calif. – Last night, Governor Gavin Newsom vetoed legislation that would have ensured comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... American Cancer Society Cancer Action Network (ACS CAN) and the University of California – aimed to enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments
... here . Sacramento, Calif. – The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients. Senate Bill 912 would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. The bill moves on to ...
More Californians with Cancer, Other Chronic Diseases, Get Access to Game-Changing Testing
... implementation of Senate Bill 496. Starting July 1st, Medi-Cal and other state-regulated health insurance plans will cover comprehensive biomarker testing when supported by medical and scientific evidence. Testing for specific biomarkers – such as gene mutations – found in blood, tissues ... including precision medicine and targeted therapies. “Nearly 60% of all cancer drugs approved in the last five years require or recommend biomarker testing before use. Improving coverage for biomarker testing across insurance types is a crucial step to reduce disparities in cancer ...
Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments
Sacramento, Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. The American Cancer Society Cancer Action Network (ACS CAN) and ... Cancer Centers. “Last year, I authored legislation to provide patients diagnosed with stages 3 and 4 cancer with prompt access to biomarker testing to inform their course of treatment. We know there are biomarker testing available for other conditions that can help healthcare ...
California Cancer Advocates Rally Virtually for Increased Access to Innovative Testing and Lifesaving Treatments
... Network (ACS CAN) volunteers met virtually with state lawmakers Tuesday and urged them to pass legislation that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. If signed into law, Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Legislation Aimed at Improving Health Outcomes, Quality of Life for Californians Heads to the Governor’s Desk
... – The California Legislature passed a bill Thursday night to ensure that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence. Senate Bill 496, sponsored by the American Cancer Society Cancer Action Network (ACS ... of California, has received strong, bipartisan support throughout the legislative process. It now heads to the governor’s desk. “Biomarker testing can help health care providers render the right treatment at the right time and is increasingly important for cancer care and the ...